Global Cancer News

New therapeutic avenue in the fight against chronic liver disease

Chronic liver disease is known as the silent killer, showing no obvious symptoms until the disease has progressed to an advanced stage. Therefore, making a proper diagnosis in the early stage of disease progression a clinical challenge. An international team of researchers, affiliated with UNIST, has identified a novel route that regulates the signaling pathways induced by extracellular matrix (ECM). This may serve as a new diagnostic marker and therapeutic target in the fight against chronic liver diseases.

To read more, please click here.